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The aim of this study was to assess the effect of statin therapy on macrophages accumulation in coronary atherosclerotic plaques by using 
optical coherence tomography (OCT).
background: OCT can identify macrophages accumulation as a high intensity signal-rich linear region with sharp attenuation.
methods: Seventy patients with unstable angina pectoris and untreated dyslipidemia were randomized to either 20 mg/day or 5 mg/day of 
atorvastatin therapy. OCT was performed to assess intermediate non-culprit lesions at baseline and 12-month follow-up.
Results: Macrophage grade decreased significantly in both groups, and the percent decrease in macrophage grade was significantly 
greater in the group receiving 20mg/day of atorvastatin compared with the group receiving 5mg/day of atorvastatin (-38% [IQR -44 to -31%] 
vs. -24% [IQR -33 to 0%], p<0.001). The percent change in macrophage grade was negatively correlated with the percent change in the 
serum HDL-C (R=-0.368, p=0.008) levels, and positively correlated with the percent change in the serum hs-CRP (R=0.308, p=0.033) 
and MMP-9 (R=0.486, p<0.001) levels; however, it was not correlated with the percent change in the serum total cholesterol (R=0.038, 
p=0.793), LDL-C (R=0.212, p=0.139), triglyceride (R=0.070, p=0.627), MDA-LDL (R=0.163, p=0.257), IL-6 (R=-0.153, p=0.288), and 
HbA1c (R=0.086, p=0.551) levels. In addition, the percent change in macrophage grade was negatively correlated with the percent change 
in fibrous cap thickness (R=-0.415, p=0.003).
conclusion: Therapy with 20 mg/day of atorvastatin provided greater decrease of macrophage accumulation in coronary plaques 
compared with 5 mg/day of atorvastatin. The decrease of macrophage accumulation was associated with the increase in serum HDL-C and 
decrease in serum inflammatory biomarkers during atorvastatin therapy.
